Cargando…
Tolperisone for the Treatment of Acute Muscle Spasm of the Back: Results from the Dose-Ranging Phase 2 STAR Study (NCT03802565)
OBJECTIVE: Use of skeletal muscle relaxants (SMRs) for acute muscle spasm is confounded by central nervous system adverse events (AEs), including somnolence. Tolperisone is an SMR that does not appear to be associated with somnolence. The aim of this study was to assess the safety and efficacy of to...
Autores principales: | Nalamachu, Srinivas, Pergolizzi, Joseph, Kaye, Randall |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695600/ https://www.ncbi.nlm.nih.gov/pubmed/33262641 http://dx.doi.org/10.2147/JPR.S278857 |
Ejemplares similares
-
An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine
por: Caron, Judy, et al.
Publicado: (2020) -
Clinical Comparative Study: Efficacy and Tolerability of Tolperisone and Thiocolchicoside in Acute Low Back Pain and Spinal Muscle Spasticity
por: Rao, Rajeev, et al.
Publicado: (2012) -
Basic Aspects of the Pharmacodynamics of Tolperisone, A Widely Applicable Centrally Acting Muscle Relaxant
por: Tekes, Kornelia
Publicado: (2014) -
Reversed phase-high performance liquid chromatographic method for simultaneous estimation of tolperisone hydrochloride and etodolac in a combined fixed dose oral formulations
por: Patel, Mit J., et al.
Publicado: (2011) -
Development and Validation of a Precise, Single HPLC Method for the Determination of Tolperisone Impurities in API and Pharmaceutical Dosage Forms
por: Raju, Thummala Veera Raghava, et al.
Publicado: (2013)